Source:http://linkedlifedata.com/resource/pubmed/id/19864666
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2009-10-29
|
pubmed:abstractText |
Myotonic dystrophy type 2 (DM2) is a dominantly inherited multisystem disorder, characterised by progressive proximal weakness, myotonia, cataracts and cardiac conduction abnormalities. Our clinical impression of an association between DM2 and autoimmune diseases or autoantibody formation has not been published previously.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1468-330X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
80
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1293-5
|
pubmed:meshHeading |
pubmed-meshheading:19864666-Autoantibodies,
pubmed-meshheading:19864666-Autoimmune Diseases,
pubmed-meshheading:19864666-Case-Control Studies,
pubmed-meshheading:19864666-Female,
pubmed-meshheading:19864666-Humans,
pubmed-meshheading:19864666-Middle Aged,
pubmed-meshheading:19864666-Myotonic Dystrophy
|
pubmed:year |
2009
|
pubmed:articleTitle |
Strong association between myotonic dystrophy type 2 and autoimmune diseases.
|
pubmed:affiliation |
Neuromuscular Centre Nijmegen, Department of Neurology (935), Radboud University Nijmegen Medical Centre, PO Box 9101, 6500 HB, Nijmegen, The Netherlands. a.tieleman@neuro.umcn.nl
|
pubmed:publicationType |
Journal Article,
Comparative Study
|